Bibliographic information

GuidelineLatent tuberculosis infection: updated and consolidated guidelines for programmatic management
Year of Publication2018
Issuing InstitutionWHO

Recommendation

Maintained
Originally developed

Either a tuberculin skin test (TST) or interferon-gamma release assay (IGRA) can be used to test for latent tuberculosis infection (LTBI)

Recommended in favor

Strong

Notes and Remarks

The availability and affordability of the tests will determine which will be chosen by clinicians and programme managers. Neither TST nor IGRA can be used to diagnose active TB disease nor for diagnostic workup of adults suspected of having active TB.

Also Featured In

This recommendation also appears in the following guidelines:

Guideline

WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1: prevention

Year2020
InstitutionWHO
Guideline

Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

Year2021
InstitutionWHO
Guideline

WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents.

Year2022
InstitutionWHO
Guideline

WHO consolidated guidelines on tuberculosis: module 3: diagnosis: tests for TB infection

Year2022
InstitutionWHO
Guideline

WHO consolidated guidelines on tuberculosis: module 6: tuberculosis and comorbidities.

Year2024
InstitutionWorld Health Organization
Guideline

WHO consolidated guidelines on tuberculosis: module 3: diagnosis

Year2025
InstitutionWorld Health Organization
Guideline

WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment, 2nd ed

Year2024
InstitutionWorld Health Organization
Guideline

WHO consolidated guidelines on tuberculosis: module 6: tuberculosis and comorbidities, 2nd ed.

Year2025
InstitutionWorld Health Organization